CA2383224A1 - Utilisation d'extraits de peau d'orange dans la prevention et le traitement du cancer - Google Patents

Utilisation d'extraits de peau d'orange dans la prevention et le traitement du cancer Download PDF

Info

Publication number
CA2383224A1
CA2383224A1 CA002383224A CA2383224A CA2383224A1 CA 2383224 A1 CA2383224 A1 CA 2383224A1 CA 002383224 A CA002383224 A CA 002383224A CA 2383224 A CA2383224 A CA 2383224A CA 2383224 A1 CA2383224 A1 CA 2383224A1
Authority
CA
Canada
Prior art keywords
extract
methoxyflavone
hydroxy
animal
resveratrol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002383224A
Other languages
English (en)
Other versions
CA2383224C (fr
Inventor
Geetha Ghai
Robert T. Rosen
Chi-Tang Ho
Kuang Yu Chen
Nitin Telang
Martin Lipkin
Mou Tuan Huang
Charles Boyd
Katalin Csiszar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Geetha Ghai
Robert T. Rosen
Chi-Tang Ho
Kuang Yu Chen
Nitin Telang
Martin Lipkin
Mou Tuan Huang
Charles Boyd
Katalin Csiszar
Rutgers, The State University Of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geetha Ghai, Robert T. Rosen, Chi-Tang Ho, Kuang Yu Chen, Nitin Telang, Martin Lipkin, Mou Tuan Huang, Charles Boyd, Katalin Csiszar, Rutgers, The State University Of New Jersey filed Critical Geetha Ghai
Publication of CA2383224A1 publication Critical patent/CA2383224A1/fr
Application granted granted Critical
Publication of CA2383224C publication Critical patent/CA2383224C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2383224A 1999-09-21 2000-09-20 Utilisation d'extraits de peau d'orange dans la prevention et le traitement du cancer Expired - Fee Related CA2383224C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15501899P 1999-09-21 1999-09-21
US60/155,018 1999-09-21
PCT/US2000/025733 WO2001021137A1 (fr) 1999-09-21 2000-09-20 Utilisation d'extraits de peau d'orange dans la prevention et le traitement du cancer

Publications (2)

Publication Number Publication Date
CA2383224A1 true CA2383224A1 (fr) 2001-03-29
CA2383224C CA2383224C (fr) 2010-12-07

Family

ID=22553801

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2383224A Expired - Fee Related CA2383224C (fr) 1999-09-21 2000-09-20 Utilisation d'extraits de peau d'orange dans la prevention et le traitement du cancer

Country Status (5)

Country Link
EP (1) EP1214040A4 (fr)
JP (1) JP2003509447A (fr)
AU (1) AU7384900A (fr)
CA (1) CA2383224C (fr)
WO (1) WO2001021137A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1147764A3 (fr) * 2000-04-19 2002-03-20 Nof Corporation Composition cosmetique
WO2002039956A2 (fr) 2000-11-15 2002-05-23 Rutgers, The State University Of New Jersey Extrait de the noir pour prevention de pathologies
US7087790B2 (en) 2003-08-29 2006-08-08 Rutgers, The State University Of New Jersey Benzotropolone derivatives and modulation of inflammatory response
US7351739B2 (en) 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
US20070042972A1 (en) * 2005-05-24 2007-02-22 Mckeever Kenneth H Compositions and methods for optimizing exercise recovery
US20070184132A1 (en) * 2006-02-09 2007-08-09 Kgk Synergize Inc Methods of treating canine osteosarcoma
WO2008035208A2 (fr) * 2006-05-19 2008-03-27 Kgk Synergize Inc Utilisation de flavonoïdes pour inhiber la croissance cellulaire
CN100422168C (zh) * 2006-06-15 2008-10-01 中国科学技术大学 橙皮素衍生物及其制备方法
DE102007037772A1 (de) * 2007-08-10 2009-02-12 Csabai, Zsolt, Dr. Ph. Antioxidantenkomplex auf Grape Vital Basis (Citrus- und/oder Traubenkern und/oder Flavonoidbasis)
JP5742050B2 (ja) * 2011-03-01 2015-07-01 国立研究開発法人農業・食品産業技術総合研究機構 Ｎｋ細胞活性化剤、及びｎｋ細胞活性化方法
EP2851072B1 (fr) 2012-05-16 2020-11-25 AAT Costech Co., Ltd. Utilisation d'un composé de flavone pour le traitement de l'obésité
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
WO2017099034A1 (fr) * 2015-12-07 2017-06-15 国立大学法人京都大学 Polythérapie à base d'inhibiteurs de signal pd-1
CN115772145A (zh) * 2022-11-29 2023-03-10 三峡大学 一种柑橘属果实提取物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220223C (fr) * 1995-05-05 2008-07-29 Hauser Inc. Isolement d'acide carnosique pur dans des extraits de romarin et de sauge par precipitation regie par le ph
JPH09176009A (ja) * 1995-12-27 1997-07-08 Inahata Koryo Kk 新規な抗変異原剤及び抗変異原性作用物質
US5830738A (en) * 1996-06-04 1998-11-03 Clemson University Extraction of pigment from plant material
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
JP3571899B2 (ja) * 1997-12-18 2004-09-29 小川香料株式会社 香味劣化抑制剤

Also Published As

Publication number Publication date
WO2001021137A1 (fr) 2001-03-29
WO2001021137A8 (fr) 2001-07-26
EP1214040A4 (fr) 2004-06-23
CA2383224C (fr) 2010-12-07
EP1214040A1 (fr) 2002-06-19
AU7384900A (en) 2001-04-24
JP2003509447A (ja) 2003-03-11

Similar Documents

Publication Publication Date Title
CA2383224A1 (fr) Utilisation d'extraits de peau d'orange dans la prevention et le traitement du cancer
CA2431196A1 (fr) Extrait de the noir pour prevention de pathologies
WO2001080843A3 (fr) Inhibition d'une proliferation cellulaire anormale avec de la camptothecine et combinaisons contenant ledit compose
GEP20053688B (en) Substituted-Triazolopyrimidines as Anticancer Agents
IL145492A0 (en) Methods and compositions for treating solid tumors
AP1666A (en) Quinolinone derivatives as tyrosine kinase inhibitors.
YU75003A (sh) Nutriciona farmaceutska formulacija koja uključuje polifenole i upotreba u tretmanu kancera
AU4451101A (en) Method and compositions for preventing hormone induced adverse effects
CA2326761A1 (fr) Agents antitumoraux
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
GEP20043322B (en) C7 Ester Substituted Taxanes as Antitumor Agents, Pharmaceutical Compositions Containing the Same and Use Thereof for Inhibiting Tumors
CA2418479A1 (fr) Promedicaments de derives de l'acide betulinique pour le traitement du cancer et du vih
WO2007147128A3 (fr) Médicament anti-cancéreux non toxique combinant de l'ascorbate, du magnésium et une naphtoquinone
GEP20033079B (en) Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency
HK1082663A1 (en) Extract with anti-tumor and anti-poisonous activity
AU4830097A (en) Use of an extract of Cimicifuga
MX9800945A (es) Uso de griseofulvina para inhibir el crecimiento de canceres.
EP0819433A3 (fr) Compositions pour améliorer l'efficacité de médicaments anti-cancéreux à l'aide de catéchine de thé et/ou de théaflavine
AU2162202A (en) Antitumor therapy comprising distamycin derivatives
WO2002062952A3 (fr) Mutants pap non cytotoxiques
NZ523606A (en) Pharmaceutical compositions and methods for use
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
IL131096A0 (en) Muscle-derived compositions
WO2001082908A3 (fr) Chimiotherapie basee sur l'utilisation de ginsenosides
WO2000059488A3 (fr) Administration amelioree de composes de vitamine e au niveau tissulaire et infracellulaire

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140922